Literature DB >> 9986809

Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.

C D Steward1, S A Stocker, J M Swenson, C M O'Hara, J R Edwards, R P Gaynes, J E McGowan, F C Tenover.   

Abstract

Fluoroquinolone resistance appears to be increasing in many species of bacteria, particularly in those causing nosocomial infections. However, the accuracy of some antimicrobial susceptibility testing methods for detecting fluoroquinolone resistance remains uncertain. Therefore, we compared the accuracy of the results of agar dilution, disk diffusion, MicroScan Walk Away Neg Combo 15 conventional panels, and Vitek GNS-F7 cards to the accuracy of the results of the broth microdilution reference method for detection of ciprofloxacin and ofloxacin resistance in 195 clinical isolates of the family Enterobacteriaceae collected from six U.S. hospitals for a national surveillance project (Project ICARE [Intensive Care Antimicrobial Resistance Epidemiology]). For ciprofloxacin, very major error rates were 0% (disk diffusion and MicroScan), 0.9% (agar dilution), and 2.7% (Vitek), while major error rates ranged from 0% (agar dilution) to 3.7% (MicroScan and Vitek). Minor error rates ranged from 12.3% (agar dilution) to 20.5% (MicroScan). For ofloxacin, no very major errors were observed, and major errors were noted only with MicroScan (3.7% major error rate). Minor error rates ranged from 8.2% (agar dilution) to 18.5% (Vitek). Minor errors for all methods were substantially reduced when results with MICs within +/-1 dilution of the broth microdilution reference MIC were excluded from analysis. However, the high number of minor errors by all test systems remains a concern.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9986809      PMCID: PMC84460     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System.

Authors:  G V Doern; B B Torres; M Jankins; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1996-07       Impact factor: 2.803

Review 2.  Fluoroquinolone antimicrobial agents.

Authors:  D C Hooper; J S Wolfson
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

3.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Increased resistance to quinolone in Catalonia, Spain.

Authors:  B Mirelis; E Miro; F Navarro; C A Ogalla; J Bonal; G Prats
Journal:  Diagn Microbiol Infect Dis       Date:  1993-02       Impact factor: 2.803

5.  Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Canadian Ciprofloxacin Study Group.

Authors:  J M Blondeau; Y Yaschuk
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

6.  Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

Authors:  C Dupeyron; N Mangeney; L Sedrati; B Campillo; P Fouet; G Leluan
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.

Authors:  P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem.

Authors:  S K Spangler; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use.

Authors:  K Waites; K Rand; S Jenkins; B Yangco; E Brookings; D Gaskins; J Lewis; K Halkias
Journal:  Diagn Microbiol Infect Dis       Date:  1994-03       Impact factor: 2.803

10.  Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.

Authors:  S Ouabdesselam; D C Hooper; J Tankovic; C J Soussy
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  5 in total

1.  Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci.

Authors:  Karen C Carroll; Anita P Borek; Chad Burger; Brian Glanz; Hasan Bhally; Susan Henciak; Diane C Flayhart
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.

Authors:  Maria Grazia Menozzi; Ulrich Eigner; Silvia Covan; Sabina Rossi; Pietro Somenzi; Giuseppe Dettori; Carlo Chezzi; Anne-Marie Fahr
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.

Authors:  Fred C Tenover; Portia P Williams; Sheila Stocker; Angela Thompson; Leigh Ann Clark; Brandi Limbago; Roberta B Carey; Susan M Poppe; Dean Shinabarger; John E McGowan
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

4.  A prevalence and molecular characterization of novel pathogenic strains of Macrococcus caseolyticus isolated from external wounds of donkeys in Khartoum State -Sudan.

Authors:  Dania E Ali; Mushal Allam; Hisham N Altayb; D Mursi; M A Adalla; N O Mohammed; Mona A M Khaier; Manal H Salih; Sarah Abusalab; M A Abbas
Journal:  BMC Vet Res       Date:  2022-05-25       Impact factor: 2.792

5.  Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.

Authors:  Lauren Becnel Boyd; Robert L Atmar; Graham L Randall; Richard J Hamill; David Steffen; Lynn Zechiedrich
Journal:  BMC Infect Dis       Date:  2008-01-15       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.